Volume 3, Issue 1: Shifting Paradigm of Type 2 Diabetes: From Neutrality to Benefit on Cardiovascular Outcomes
e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 3, Issue 1)
Nurses and health care professionals involved in the care of patients with diabetes.
After participating in this activity, the participant will demonstrate the ability to:
- Identify antihyperglycemic medications that have been shown to reduce composite
cardiovascular disease risk (death from cardiovascular causes, nonfatal myocardial
infarction, and nonfatal stroke) in patients with type 2 diabetes at high risk for CVD.
- Discuss the association between DPP-4 inhibitors and congestive heart failure.
- Describe expected clinical outcomes when using metformin in patients with previous
historical contraindications or precautions (congestive heart failure, chronic kidney
disease, and chronic liver disease).
- 1.00 ANCC
- 1.00 Attendance